Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Guttman

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Neurobiology of Disease|June 24, 2015
Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulationJunchao Tong, Lee-Cyn Ang, Belinda Williams, et al.
Annals of Neurology|July 12, 2002
Brain proteasomal function in sporadic Parkinson's disease and related disordersYoshiaki Furukawa, Sophie Vigouroux, Henry Wong, et al.
Annals of Neurology|November 2, 2005
Preclinical Huntington's disease: compensatory brain responses during learningAndrew Feigin, Maria-Felice Ghilardi, Chaorui Huang, et al.
Brain : a Journal of Neurology|October 21, 2017
Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disordersJunchao Tong, Gausiha Rathitharan, Jeffrey H Meyer, et al.
Journal of Huntington'S Disease|April 12, 2021
The Impact of Upcoming Treatments in Huntington's Disease: Resource Capacity Limitations and Access to Care ImplicationsMark Guttman, Marco Pedrazzoli, Marina Ponomareva, et al.
Journal of Parkinson'S Disease|November 19, 2016
Regular Exercise, Quality of Life, and Mobility in Parkinson's Disease: A Longitudinal Analysis of National Parkinson Foundation Quality Improvement Initiative DataMiriam R Rafferty, Peter N Schmidt, Sheng T Luo, et al.
Synapse (New York, N.Y.)|April 24, 2003
VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PETRaúl De La Fuente-Fernández, Sarah Furtado, Mark Guttman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 19, 2005
Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessmentMark Stacy, Annette Bowron, Mark Guttman, et al.
Neurology|January 1, 2016
D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesiaDoris E Payer, Mark Guttman, Stephen J Kish, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 26, 2008
Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker?Isabelle Boileau, Pablo Rusjan, Sylvain Houle, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Neurobiology of Disease|June 24, 2015
Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulationJunchao Tong, Lee-Cyn Ang, Belinda Williams, et al.
Annals of Neurology|July 12, 2002
Brain proteasomal function in sporadic Parkinson's disease and related disordersYoshiaki Furukawa, Sophie Vigouroux, Henry Wong, et al.
Annals of Neurology|November 2, 2005
Preclinical Huntington's disease: compensatory brain responses during learningAndrew Feigin, Maria-Felice Ghilardi, Chaorui Huang, et al.
Brain : a Journal of Neurology|October 21, 2017
Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disordersJunchao Tong, Gausiha Rathitharan, Jeffrey H Meyer, et al.
Journal of Huntington'S Disease|April 12, 2021
The Impact of Upcoming Treatments in Huntington's Disease: Resource Capacity Limitations and Access to Care ImplicationsMark Guttman, Marco Pedrazzoli, Marina Ponomareva, et al.
Journal of Parkinson'S Disease|November 19, 2016
Regular Exercise, Quality of Life, and Mobility in Parkinson's Disease: A Longitudinal Analysis of National Parkinson Foundation Quality Improvement Initiative DataMiriam R Rafferty, Peter N Schmidt, Sheng T Luo, et al.
Synapse (New York, N.Y.)|April 24, 2003
VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PETRaúl De La Fuente-Fernández, Sarah Furtado, Mark Guttman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 19, 2005
Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessmentMark Stacy, Annette Bowron, Mark Guttman, et al.
Neurology|January 1, 2016
D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesiaDoris E Payer, Mark Guttman, Stephen J Kish, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 26, 2008
Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker?Isabelle Boileau, Pablo Rusjan, Sylvain Houle, et al.
Pageof 7